Corporate Strategy Manager

Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.

Heartflow is a publicly traded company (HTFL) that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 750,000 patients worldwide.  

Corporate Strategy at Heartflow helps answer the company’s most important questions: where should we play, how will we win, what should we prioritize, and how should the company evolve as it scales. As Manager, Corporate Strategy, you will partner with executive leadership to shape enterprise strategy, assess new markets and portfolio opportunities, translate strategy into the long-range plan, and drive a small number of high-priority initiatives that cut across functions. You will combine rigorous analytics, strategic judgment, and executive communication to turn ambiguous questions into clear choices and action. This role is fundamentally about setting direction, sharpening choices, and helping Heartflow make better enterprise-level decisions.

Job Responsibilities

Enterprise Strategy & Portfolio Direction

• Corporate Strategy & Long-Range Planning: Partner with executive leadership and Finance to shape Heartflow’s enterprise strategy, strategic priorities, and long-range plan, linking market opportunity, competitive position, product roadmap, financial ambition, and organizational capabilities.
• Market, Portfolio & Adjacency Strategy: Evaluate where Heartflow should play next across products, clinical use cases, customer segments, geographies, and adjacent markets. Size opportunities, assess strategic fit and right-to-win, and develop clear recommendations on where to invest, sequence, or deprioritize.
• Strategic Opportunity Assessment: Frame and answer high-stakes, ambiguous business questions using market research, competitive analysis, customer and clinical insights, financial modeling, and scenario analysis. Translate analysis into explicit choices, trade-offs, and recommendations.